{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:16:22Z","timestamp":1783224982411,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003141","name":"CONAHCYT","doi-asserted-by":"crossref","award":["(1138096)"],"award-info":[{"award-number":["(1138096)"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]},{"name":"COVEYCIDET","award":["11112017\/2023."],"award-info":[{"award-number":["11112017\/2023."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11686-024-00986-w","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:56:44Z","timestamp":1736269004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Expression Analysis of Thirteen Genes in Response to Nifurtimox and Benznidazole in Mexican Isolates of Trypanosoma cruzi by Digital PCR"],"prefix":"10.1007","volume":"70","author":[{"given":"Paulina","family":"Ochoa-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aracely","family":"L\u00f3pez-Monteon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"L\u00f3pez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca Georgina","family":"Manning-Cela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Ramos-Ligonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"986_CR1","unstructured":"WHO, Chagas (2022) disease. https:\/\/www.paho.org\/en\/topics\/chagas-disease. Chagas disease (American trypanosomiasis).https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis)"},{"key":"986_CR2","unstructured":"Chagas Coallition (2023) Chagas Disease: The Scope and Impact of the Problem. https:\/\/www.coalicionchagas.org\/en\/why-is-important-"},{"issue":"4","key":"986_CR3","doi-asserted-by":"publisher","first-page":"e0006859","DOI":"10.1371\/journal.pntd.0006859","volume":"13","author":"A Arnal","year":"2019","unstructured":"Arnal A, Waleckx E, Rico-Ch\u00e1vez O, Herrera C, Dumonteil E (2019) Estimating the current burden of Chagas disease in Mexico: a systematic review and meta-analysis of epidemiological surveys from 2006 to 2017. PLoS Negl Trop Dis 13(4):e0006859. https:\/\/doi.org\/10.1371\/journal.pntd.0006859","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"986_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1590\/s0074-02762009000700021","volume":"104","author":"B Zingales","year":"2009","unstructured":"Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, Fernandes O, Guhl F, Lages-Silva E, Macedo AM, Machado CR, Miles MA, Romanha AJ, Sturm NR, Tibayrenc M, Schijman AG, Meeting SS (2009) A new consensus for Trypanosoma Cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 104(7):1051\u20131054. https:\/\/doi.org\/10.1590\/s0074-02762009000700021","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"986_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.meegid.2011.12.009","volume":"12","author":"B Zingales","year":"2012","unstructured":"Zingales B, Miles MA, Campbell DA, Tibayrenc M, Macedo AM, Teixeira MM, Schijman AG, Llewellyn MS, Lages-Silva E, Machado CR, Andrade SG, Sturm NR (2012) The revised Trypanosoma Cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol J Mol Epidemiol Evolut Genet Infect Dis 12(2):240\u2013253. https:\/\/doi.org\/10.1016\/j.meegid.2011.12.009","journal-title":"Infect Genet Evol J Mol Epidemiol Evolut Genet Infect Dis"},{"key":"986_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.actatropica.2015.07.015)","volume":"151","author":"L Lima","year":"2015","unstructured":"Lima L, Espinosa-\u00c1lvarez O, Ortiz PA, Trejo-Var\u00f3n JA, Carranza JC, Pinto CM, Serrano MG, Buck GA, Camargo EP, Teixeira MM (2015) Genetic diversity of Trypanosoma Cruzi in bats, and multilocus phylogenetic and phylogeographical analyses supporting Tcbat as an independent DTU (discrete typing unit). Acta Trop 151:166\u2013177. https:\/\/doi.org\/10.1016\/j.actatropica.2015.07.015)","journal-title":"Acta Trop"},{"issue":"4","key":"986_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/pathogens8040197","volume":"8","author":"S Revollo","year":"2019","unstructured":"Revollo S, Oury B, Vela A, Tibayrenc M, Sereno D (2019) In vitro benznidazole and nifurtimox susceptibility profile of Trypanosoma Cruzi strains belonging to discrete typing units TcI, TcII, and TcV. Pathogens (Basel Switzerland) 8(4):197. https:\/\/doi.org\/10.3390\/pathogens8040197","journal-title":"Pathogens (Basel Switzerland)"},{"issue":"3","key":"986_CR8","doi-asserted-by":"publisher","first-page":"e0009269","DOI":"10.1371\/journal.pntd.0009269)","volume":"15","author":"A Vela","year":"2021","unstructured":"Vela A, Coral-Almeida M, Sereno D, Costales JA, Barnab\u00e9 C, Breni\u00e8re SF (2021) In vitro susceptibility of Trypanosoma Cruzi discrete typing units (DTUs) to benznidazole: a systematic review and meta-analysis. PLoS Negl Trop Dis 15(3):e0009269. https:\/\/doi.org\/10.1371\/journal.pntd.0009269)","journal-title":"PLoS Negl Trop Dis"},{"key":"986_CR9","doi-asserted-by":"publisher","first-page":"112020","DOI":"10.1016\/j.biopha.2021.112020.)","volume":"142","author":"P Garc\u00eda-Huertas","year":"2021","unstructured":"Garc\u00eda-Huertas P, Cardona-Castro N (2021) Advances in the treatment of Chagas disease: promising new drugs, plants and targets. Biomed Pharmacother 142:112020. https:\/\/doi.org\/10.1016\/j.biopha.2021.112020.)","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"986_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/bcp.14700","volume":"88","author":"F Lascano","year":"2022","unstructured":"Lascano F, Garc\u00eda Bournissen F, Altcheh J (2022) Review of pharmacological options for the treatment of Chagas disease. Br J Clin Pharmacol 88(2):383\u2013402. https:\/\/doi.org\/10.1111\/bcp.14700","journal-title":"Br J Clin Pharmacol"},{"issue":"15","key":"986_CR11","doi-asserted-by":"publisher","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","volume":"286","author":"BS Hall","year":"2011","unstructured":"Hall BS, Bot C, Wilkinson SR (2011) Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. J Biol Chem 286(15):13088\u201313095. https:\/\/doi.org\/10.1074\/jbc.M111.230847","journal-title":"J Biol Chem"},{"issue":"1","key":"986_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/AAC","volume":"56","author":"BS Hall","year":"2012","unstructured":"Hall BS, Wilkinson SR (2012) Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation. Antimicrob Agents Chemother 56(1):115\u2013123. https:\/\/doi.org\/10.1128\/AAC","journal-title":"Antimicrob Agents Chemother"},{"key":"986_CR13","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1017\/S1462399409001252","volume":"11","author":"SR Wilkinson","year":"2009","unstructured":"Wilkinson SR, Kelly JM (2009) Trypanocidal drugs: mechanisms, resistance and new targets. Expert Rev Mol Med 11:e31. https:\/\/doi.org\/10.1017\/S1462399409001252","journal-title":"Expert Rev Mol Med"},{"key":"986_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1756-3305-4-169","volume":"4","author":"AM Mej\u00eda-Jaramillo","year":"2011","unstructured":"Mej\u00eda-Jaramillo AM, Fern\u00e1ndez GJ, Palacio L, Triana-Ch\u00e1vez O (2011) Gene expression study using real-time PCR identifies an NTR gene as a major marker of resistance to benzonidazole in Trypanosoma Cruzi. Parasit Vectors 4:169. https:\/\/doi.org\/10.1186\/1756-3305-4-169","journal-title":"Parasit Vectors"},{"issue":"4","key":"986_CR15","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1007\/s11686-022-00608-3","volume":"67","author":"J L\u00f3pez-Dom\u00ednguez","year":"2022","unstructured":"L\u00f3pez-Dom\u00ednguez J, L\u00f3pez-Monteon A, Ochoa-Mart\u00ednez P, Dumonteil E, Barnab\u00e9 C, Waleckx E, Hern\u00e1ndez-Giles RG, Ramos-Ligonio A (2022) Molecular characterization of four Mexican isolates of Trypanosoma Cruzi and their Profile susceptibility to Nifurtimox. Acta Parasitol 67(4):1584\u20131593. https:\/\/doi.org\/10.1007\/s11686-022-00608-3","journal-title":"Acta Parasitol"},{"key":"986_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0166-6851(98)00037-1","volume":"93","author":"SMF Murta","year":"1998","unstructured":"Murta SMF, Gazzinelli RT, Brener Z, Romanha AJ (1998) Molecular characterization of susceptible and naturally resistant strains of Trypanosoma Cruzi to benznidazole and nifurtimox. Mol Biochem Parasitol 93:203\u2013214","journal-title":"Mol Biochem Parasitol"},{"key":"986_CR17","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1590\/S0037-86822011005000058","volume":"44","author":"C G\u00f3mez-Hern\u00e1ndez","year":"2011","unstructured":"G\u00f3mez-Hern\u00e1ndez C, Resende-Oliveira K, Nogueira G, Rocha L et al (2011) Molecular characterization of Trypanosoma Cruzi Mexican strains and their behavior in the mouse experimental model. Rev Soc Bras Med Trop 44:684\u2013690","journal-title":"Rev Soc Bras Med Trop"},{"key":"986_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/vbz.2006.0604","volume":"7","author":"F Le\u00f3n-P\u00e9rez","year":"2007","unstructured":"Le\u00f3n-P\u00e9rez F, G\u00f3mez-Garc\u00eda L, Alejandre-Aguilar R, L\u00f3pez R et al (2007) Mexican Trypanosoma Cruzi isolates: in vitro susceptibility of epimastigotes to anti-trypanosoma cruzi drugs and metacyclic forms to complement-mediated lysis. Vector Borne Zoonot Dis 7:330\u2013336","journal-title":"Vector Borne Zoonot Dis"},{"issue":"3","key":"986_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/vbz.2012.1072","volume":"13","author":"I Mart\u00ednez","year":"2013","unstructured":"Mart\u00ednez I, Nogueda B, Mart\u00ednez-Hern\u00e1ndez F, Espinoza B (2013) Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma Cruzi strains and their susceptibility to nifurtimox and benznidazole. Vector Borne Zoonotic Dis 13(3):181\u2013187. https:\/\/doi.org\/10.1089\/vbz.2012.1072","journal-title":"Vector Borne Zoonotic Dis"},{"key":"986_CR20","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1001\/jama.298.18.2171","volume":"298","author":"C Bern","year":"2007","unstructured":"Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO (2007) Et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 298:2171\u20132181","journal-title":"JAMA"},{"issue":"5","key":"986_CR21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","volume":"97","author":"PA Sales-Junior","year":"2017","unstructured":"Sales-Junior PA, Molina I, Murta SMF, S\u00e1nchez-Montalv\u00e1 A, Salvador F, Corr\u00eaa-Oliveira R et al (2017) Experimental and clinical treatment of Chagas disease: a review. Am J Trop Med Hyg 97(5):1289\u20131303","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"986_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/156802662303230202104841","volume":"23","author":"J de Moraes","year":"2023","unstructured":"de Moraes J (2023) Recent advances in the Discovery of Antiparasitic drugs for Chagas Disease and Malaria. Curr Top Med Chem 23(3):158. https:\/\/doi.org\/10.2174\/156802662303230202104841","journal-title":"Curr Top Med Chem"},{"key":"986_CR23","doi-asserted-by":"crossref","unstructured":"Franco J, Scarone L, Comini MA (2018) Chapter Three - Drugs and Drug Resistance in African and American Trypanosomiasis, Editor(s): Maurizio Botta, Annual Reports in Medicinal Chemistry, Academic Press,Volume 51, Pages 97\u2013133","DOI":"10.1016\/bs.armc.2018.08.003"},{"issue":"6","key":"986_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.freeradbiomed.2008.05.028","volume":"45","author":"F Irigo\u00edn","year":"2008","unstructured":"Irigo\u00edn F, Cibils L, Comini MA, Wilkinson SR, Floh\u00e9 L, Radi R (2008) Insights into the redox biology of Trypanosoma Cruzi: Trypanothione metabolism and oxidant detoxification. Free Radic Biol Med 45(6):733\u2013742. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.05.028","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"986_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd4683","volume":"14","author":"K Katsuno","year":"2015","unstructured":"Katsuno K, Burrows JN, Duncan K, van Hooft R, Kaneko T, Kita K, Mowbray CE, Schmatz D, Warner P, Slingsby BT (2015) Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nat Rev Drug Discov 14(11):751\u2013758. https:\/\/doi.org\/10.1038\/nrd4683","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"986_CR26","doi-asserted-by":"publisher","first-page":"e000177","DOI":"10.1099\/mgen.0.000177","volume":"4","author":"L Bern\u00e1","year":"2018","unstructured":"Bern\u00e1 L, Rodriguez M, Chiribao ML, Parodi-Talice A, Pita S, Rijo G, Alvarez-Valin F, Robello C (2018) Expanding an expanded genome: longread sequencing of Trypanosoma Cruzi. Microb Genom 4(5):e000177. https:\/\/doi.org\/10.1099\/mgen.0.000177","journal-title":"Microb Genom"},{"issue":"2","key":"986_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.exppara.2005.12.015","volume":"113","author":"F Caro","year":"2006","unstructured":"Caro F, Bercovich N, Atorrasagasti C, Levin MJ, V\u00e1zquez MP (2006) Trypanosoma Cruzi: analysis of the complete PUF RNA-binding protein family. Exp Parasitol 113(2):112\u2013124. https:\/\/doi.org\/10.1016\/j.exppara.2005.12.015","journal-title":"Exp Parasitol"},{"issue":"4","key":"986_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s1471-4922(03)00035-7","volume":"19","author":"I D\u2019Orso","year":"2003","unstructured":"D\u2019Orso I, De Gaudenzi JG, Frasch AC (2003) RNA-binding proteins and mRNA turnover in trypanosomes. Trends Parasitol 19(4):151\u2013155. https:\/\/doi.org\/10.1016\/s1471-4922(03)00035-7","journal-title":"Trends Parasitol"},{"issue":"9","key":"986_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1084\/jem.20020885","volume":"196","author":"BK Kubata","year":"2002","unstructured":"Kubata BK, Kabututu Z, Nozaki T, Munday CJ, Fukuzumi S, Ohkubo K, Lazarus M, Maruyama T, Martin SK, Duszenko M, Urade Y (2002) A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma Cruzi. J Exp Med 196(9):1241\u20131251. https:\/\/doi.org\/10.1084\/jem.20020885","journal-title":"J Exp Med"},{"issue":"2","key":"986_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.molbiopara.2005.12.001.)","volume":"146","author":"SM Murta","year":"2006","unstructured":"Murta SM, Krieger MA, Montenegro LR, Campos FF, Probst CM, Avila AR, Muto NH, de Oliveira RC, Nunes LR, Nird\u00e9 P, Bruna-Romero O, Goldenberg S, Romanha AJ (2006) Deletion of copies of the gene encoding old yellow enzyme (TcOYE), a NAD(P)H flavin oxidoreductase, associates with in vitro-induced benznidazole resistance in Trypanosoma Cruzi. Mol Biochem Parasitol 146(2):151\u2013162. https:\/\/doi.org\/10.1016\/j.molbiopara.2005.12.001.)","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"986_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/infdis\/jis331.9","volume":"206","author":"AM Mejia","year":"2012","unstructured":"Mejia AM, Hall BS, Taylor MC, G\u00f3mez-Palacio A, Wilkinson SR, Triana-Ch\u00e1vez O, Kelly JM (2012) Benznidazole-resistance in Trypanosoma Cruzi is a readily acquired trait that can arise independently in a single population. J Infect Dis 206(2):220\u2013228. https:\/\/doi.org\/10.1093\/infdis\/jis331.9","journal-title":"J Infect Dis"},{"key":"986_CR32","doi-asserted-by":"publisher","unstructured":"Campos MC, Leon LL, Taylor MC, Kelly JM (2014) Benznidazole-resistance in Trypanosoma Cruzi: evidence that distinct mechanisms can act in concert. Mol Biochem Parasitol 19317\u201319. https:\/\/doi.org\/10.1016\/j.molbiopara.2014.01.002","DOI":"10.1016\/j.molbiopara.2014.01.002"},{"key":"986_CR33","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/srep04703","volume":"4","author":"CB Moraes","year":"2014","unstructured":"Moraes CB, Giardini MA, Kim H, Franco CH, Araujo-Junior AM, Schenkman S, Chatelain E, Freitas-Junior LH (2014) Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma Cruzi: implications for Chagas disease drug discovery and development. Sci Rep 4:4703. https:\/\/doi.org\/10.1038\/srep04703","journal-title":"Sci Rep"},{"issue":"1","key":"986_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13071-023-05775-4","volume":"16","author":"DA Lima","year":"2023","unstructured":"Lima DA, Gon\u00e7alves LO, Reis-Cunha JL, Guimar\u00e3es PAS, Ruiz JC, Liarte DB, Murta SMF (2023) Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma Cruzi populations. Parasit Vectors 16(1):167. https:\/\/doi.org\/10.1186\/s13071-023-05775-4","journal-title":"Parasit Vectors"},{"issue":"1\u20132","key":"986_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.actatropica.2006.10.004","volume":"100","author":"FB Nogueira","year":"2006","unstructured":"Nogueira FB, Krieger MA, Nird\u00e9 P, Goldenberg S, Romanha AJ, Murta SM (2006) Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in Trypanosoma Cruzi population with in vitro-induced resistance to benznidazole. Acta Trop 100(1\u20132):119\u2013132. https:\/\/doi.org\/10.1016\/j.actatropica.2006.10.004","journal-title":"Acta Trop"},{"issue":"1","key":"986_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.molbiopara.2008.03.007","volume":"160","author":"P Portal","year":"2008","unstructured":"Portal P, Fern\u00e1ndez Villamil S, Alonso GD, De Vas MG, Flawi\u00e1 MM, Torres HN, Paveto C (2008) Multiple NADPH-cytochrome P450 reductases from Trypanosoma Cruzi suggested role on drug resistance. Mol Biochem Parasitol 160(1):42\u201351. https:\/\/doi.org\/10.1016\/j.molbiopara.2008.03.007","journal-title":"Mol Biochem Parasitol"},{"issue":"9","key":"986_CR37","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s00436-020-06779-0","volume":"119","author":"R Mart\u00edn-Escolano","year":"2020","unstructured":"Mart\u00edn-Escolano R, Mart\u00edn-Escolano J, Ballesteros-Garrido R, Cirauqui N, Abarca B, Rosales MJ, S\u00e1nchez-Moreno M, Ballesteros R, Mar\u00edn C (2020) Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma Cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition. Parasitol Res 119(9):2943\u20132954. https:\/\/doi.org\/10.1007\/s00436-020-06779-0","journal-title":"Parasitol Res"},{"issue":"2","key":"986_CR38","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/s0166-6851(97)00207-7","volume":"90","author":"C Robello","year":"1997","unstructured":"Robello C, Navarro P, Castanys S, Gamarro F (1997) A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma Cruzi. Mol Biochem Parasitol 90(2):525\u2013535. https:\/\/doi.org\/10.1016\/s0166-6851(97)00207-7","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"986_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0166-6851(02)00019-1","volume":"121","author":"CA Machado","year":"2002","unstructured":"Machado CA, Ayala FJ (2002) Sequence variation in the dihydrofolate reductase-thymidylate synthase (DHFR-TS) and trypanothione reductase (TR) genes of Trypanosoma Cruzi. Mol Biochem Parasitol 121(1):33\u201347. https:\/\/doi.org\/10.1016\/s0166-6851(02)00019-1","journal-title":"Mol Biochem Parasitol"},{"issue":"3","key":"986_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/protein\/gzx004","volume":"30","author":"KS Anderson","year":"2017","unstructured":"Anderson KS (2017) Understanding the molecular mechanism of substrate channeling and domain communication in protozoal bifunctional TS-DHFR. Protein Eng Des Sel 30(3):253\u2013261. https:\/\/doi.org\/10.1093\/protein\/gzx004","journal-title":"Protein Eng Des Sel"},{"issue":"9","key":"986_CR41","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/pathogens11090988","volume":"11","author":"KM da Costa","year":"2022","unstructured":"da Costa KM, Valente RDC, Fonseca LMD, Freire-de-Lima L, Previato JO, Mendon\u00e7a-Previato L (2022) The history of the ABC Proteins in Human trypanosomiasis pathogens. Pathogens 11(9):988. https:\/\/doi.org\/10.3390\/pathogens11090988","journal-title":"Pathogens"},{"key":"986_CR42","doi-asserted-by":"publisher","unstructured":"Bontempi IA, Bizai ML, Ortiz S, Manattini S, Fabbro D, Solari A et al (2016) Simple methodology to directly genotype Trypanosoma Cruzi discrete typing units in single and mixed infections from human blood samples. Infect Genet Evol 43123\u2013129. https:\/\/doi.org\/10.1016\/j.meegid.2016.05.026","DOI":"10.1016\/j.meegid.2016.05.026"},{"issue":"3","key":"986_CR43","doi-asserted-by":"publisher","first-page":"111121","DOI":"10.1016\/j.celrep.2022.111121","volume":"40","author":"N Douanne","year":"2022","unstructured":"Douanne N, Dong G, Amin A, Bernardo L, Blanchette M, Langlais D, Olivier M, Fernandez-Prada C (2022) Leishmania parasites exchange drug-resistance genes through extracellular vesicles. Cell Rep 40(3):111121. https:\/\/doi.org\/10.1016\/j.celrep.2022.111121","journal-title":"Cell Rep"},{"key":"986_CR44","doi-asserted-by":"publisher","first-page":"926699","DOI":"10.3389\/fcimb.2022.926699","volume":"12","author":"J Almeida-Silva","year":"2022","unstructured":"Almeida-Silva J, Menezes DS, Fernandes JMP, Almeida MC, Vasco-Dos-Santos DR, Saraiva RM, Vi\u00e7osa AL, Perez SAC, Andrade SG, Suarez-Fontes AM, Vannier-Santos MA (2022) The repositioned drugs disulfiram\/diethyldithiocarbamate combined to benznidazole: searching for Chagas disease selective therapy, preventing toxicity and drug resistance. Front Cell Infect Microbiol 12:926699. https:\/\/doi.org\/10.3389\/fcimb.2022.926699","journal-title":"Front Cell Infect Microbiol"},{"issue":"18","key":"986_CR45","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2174\/0929867322666150521091652","volume":"22","author":"MH Branquinha","year":"2015","unstructured":"Branquinha MH, Oliveira SS, Sangenito LS, Sodre CL, Kneipp LF, d\u2019Avila-Levy CM, Santos AL (2015) Cruzipain: an update on its potential as Chemotherapy Target against the Human Pathogen Trypanosoma Cruzi. Curr Med Chem 22(18):2225\u20132235. https:\/\/doi.org\/10.2174\/0929867322666150521091652","journal-title":"Curr Med Chem"},{"issue":"1","key":"986_CR46","doi-asserted-by":"publisher","first-page":"11200","DOI":"10.1038\/s41598-021-90719-0","volume":"11","author":"JW de Freitas Oliveira","year":"2021","unstructured":"de Freitas Oliveira JW, Torres TM, Moreno CJG, Amorim-Carmo B, Damasceno IZ, Soares AKMC, da Silva Barbosa J, Rocha HAO, Silva MS (2021) Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma Cruzi. Sci Rep 11(1):11200. https:\/\/doi.org\/10.1038\/s41598-021-90719-0","journal-title":"Sci Rep"},{"issue":"5","key":"986_CR47","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/mmi.13830","volume":"106","author":"L Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez L, Garc\u00eda-Huertas P, Triana-Ch\u00e1vez O, Garc\u00eda GA, Murta SMF, Mej\u00eda-Jaramillo AM (2017) Aldo-keto reductase and alcohol dehydrogenase contribute to benznidazole natural resistance in Trypanosoma Cruzi. Mol Microbiol 106(5):704\u2013718. https:\/\/doi.org\/10.1111\/mmi.13830","journal-title":"Mol Microbiol"},{"issue":"5","key":"986_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","volume":"81","author":"LS Filardi","year":"1987","unstructured":"Filardi LS, Brener Z (1987) Susceptibility and natural resistance of Trypanosoma Cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81(5):755\u2013759. https:\/\/doi.org\/10.1016\/0035-9203(87)90020-4","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"986_CR49","doi-asserted-by":"publisher","first-page":"e1009745","DOI":"10.1371\/journal.pcbi.1009745","volume":"18","author":"MZ Ali","year":"2022","unstructured":"Ali MZ, Brewster RC (2022) Controlling gene expression timing through gene regulatory architecture. PLoS Comput Biol 18(1):e1009745. https:\/\/doi.org\/10.1371\/journal.pcbi.1009745","journal-title":"PLoS Comput Biol"},{"key":"986_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.10.436","volume":"130","author":"AC Mes\u00edas","year":"2019","unstructured":"Mes\u00edas AC, Sasoni N, Arias DG, P\u00e9rez Brand\u00e1n C, Orban OCF, Kunick C, Robello C, Comini MA, Garg NJ, Zago MP (2019) Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma Cruzi. Free Radic Biol Med 130:23\u201334. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.436","journal-title":"Free Radic Biol Med"},{"key":"986_CR51","doi-asserted-by":"publisher","first-page":"101231","DOI":"10.1016\/j.redox.2019.101231","volume":"26","author":"Z Gonz\u00e1lez-Ch\u00e1vez","year":"2019","unstructured":"Gonz\u00e1lez-Ch\u00e1vez Z, V\u00e1zquez C, Mejia-Tlachi M, M\u00e1rquez-Due\u00f1as C, Manning-Cela R, Encalada R, Rodr\u00edguez-Enr\u00edquez S, Michels PAM, Moreno-S\u00e1nchez R, Saavedra E (2019) Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma Cruzi contributing to drug resistance and infectivity. Redox Biol 26:101231. https:\/\/doi.org\/10.1016\/j.redox.2019.101231","journal-title":"Redox Biol"},{"key":"986_CR52","doi-asserted-by":"publisher","unstructured":"Machado-Silva A, Cerqueira PG, Grazielle-Silva V, Gadelha FR, Peloso Ede F, Teixeira SM, Machado CR How Trypanosoma cruzi deals with oxidative stress: antioxidant defence and DNA repair pathways. Mutat Res Rev Mutat Res 2016 Jan-Mar;767:8\u201322. https:\/\/doi.org\/10.1016\/j.mrrev.2015.12.003","DOI":"10.1016\/j.mrrev.2015.12.003"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00986-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-024-00986-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00986-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T10:10:35Z","timestamp":1740996635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-024-00986-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1007\/s11686-024-00986-w","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"20 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15"}}